ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Geriatric Medicine

Top Geriatric Medicine Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HOSAM KAMEL M.D.

Geriatric Medicine

32,322

$1.83M

707
639 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $52

BILAL NAEEM MD

Geriatric Medicine

22,866

$1.05M

560
515 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $52

GRETCHEN OROSZ MD

Geriatric Medicine

20,385

$910K

587
581 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $52

MERVIN TERRELL M.D.

Geriatric Medicine

19,891

$733K

665
658 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $52

DAVID LIU M.D.

Geriatric Medicine

14,260

$1.02M

612
557 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $52

BUSHRA SHAH M.D.

Geriatric Medicine

12,220

$625K

501
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $52

KOYIA FIGURES M.D.

Geriatric Medicine

12,179

$750K

379
327 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $52

ARLENE NEPOMUCENO M.D.

Geriatric Medicine

11,112

$654K

660
654 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $52

TIMOTHY SIMMONS MD

Geriatric Medicine

11,038

$680K

303
276 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $52

THOMAS MULLIGAN MD

Geriatric Medicine

10,987

$234K

418
380 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$21
Average prescription price

Avg: $52

OUMITANA KAJKENOVA MD

Geriatric Medicine

10,914

$529K

421
375 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $52

ANN RIGGS MD

Geriatric Medicine

10,521

$493K

402
371 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $52

MARY SHINN MD

Geriatric Medicine

10,161

$510K

584
579 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $52

RALUCA ROSCA-SICHITIU M.D.

Geriatric Medicine

9,755

$547K

467
410 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $52

NOREEN HASAN M.D.

Geriatric Medicine

9,659

$198K

418
374 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$21
Average prescription price

Avg: $52

AMY IRWIN M.D.

Geriatric Medicine

9,516

$491K

460
437 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $52

CLAUDIA TOLLESON M. D.

Geriatric Medicine

9,473

$553K

270
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $52

THOMAS CAIN M.D.

Geriatric Medicine

9,442

$589K

408
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $52

BURCU OZDEMIR MD

Geriatric Medicine

9,337

$555K

441
426 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $52

RANDY SHINN MD

Geriatric Medicine

8,790

$481K

645
637 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $52

PRIYA MENDIRATTA MD

Geriatric Medicine

7,876

$443K

358
328 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $52

DAVID LIPSCHITZ MD

Geriatric Medicine

4,400

$271K

419
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $52

SUNBAL ZAFAR M.D.

Geriatric Medicine

4,119

$612K

3363
2944 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

85%
prescriptions for brand name drugs

Avg: 26%

$149
Average prescription price

Avg: $52

KIMBERLY CURSEEN MD

Geriatric Medicine

3,960

$183K

184
173 are 65+

25%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $52

GOHAR AZHAR M.D.

Geriatric Medicine

3,833

$161K

192
184 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank